Latest progress in the development of cyclooxygenase-2 pathway inhibitors targeting microsomal prostaglandin E synthase-1.
作者信息
LaBorde Krista, Lu Renzhong, Ruan Ke-He
机构信息
Center for Experimental Therapeutics & Pharmacoinformatics & Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, TX 77004, USA.
出版信息
Future Med Chem. 2022 Mar;14(6):385-388. doi: 10.4155/fmc-2021-0317. Epub 2022 Jan 5.
Abstract
摘要
相似文献
1
Latest progress in the development of cyclooxygenase-2 pathway inhibitors targeting microsomal prostaglandin E synthase-1.靶向微粒体前列腺素E合酶-1的环氧化酶-2途径抑制剂的最新研究进展
Future Med Chem. 2022 Mar;14(6):385-388. doi: 10.4155/fmc-2021-0317. Epub 2022 Jan 5.
2
Identification of the two-phase mechanism of arachidonic acid regulating inflammatory prostaglandin E2 biosynthesis by targeting COX-2 and mPGES-1.通过靶向COX-2和mPGES-1鉴定花生四烯酸调节炎症性前列腺素E2生物合成的双相机制。
Arch Biochem Biophys. 2016 Aug 1;603:29-37. doi: 10.1016/j.abb.2016.04.011. Epub 2016 May 10.
3
Roles of cyclooxygenase 2 and microsomal prostaglandin E synthase 1 in rat acid reflux oesophagitis.环氧化酶2和微粒体前列腺素E合酶1在大鼠酸性反流性食管炎中的作用
Gut. 2006 Apr;55(4):450-6. doi: 10.1136/gut.2005.081943. Epub 2005 Oct 6.
4
Microsomal prostaglandin E synthase-1 and cyclooxygenase-2 are both required for ischaemic excitotoxicity.微粒体前列腺素 E 合酶-1 和环氧化酶-2 对于缺血性兴奋毒性都是必需的。
Br J Pharmacol. 2010 Mar;159(5):1174-86. doi: 10.1111/j.1476-5381.2009.00595.x. Epub 2010 Jan 29.
5
Inhibition of microsomal prostaglandin E synthase-1 by aminothiazoles decreases prostaglandin E2 synthesis in vitro and ameliorates experimental periodontitis in vivo.氨基噻唑类化合物抑制微粒体前列腺素 E 合酶-1 可减少体外前列腺素 E2 的合成，并改善体内实验性牙周炎。
FASEB J. 2013 Jun;27(6):2328-41. doi: 10.1096/fj.12-214445. Epub 2013 Feb 27.
6
Fatty acid-binding protein 5 controls microsomal prostaglandin E synthase 1 (mPGES-1) induction during inflammation.脂肪酸结合蛋白 5 控制炎症期间微粒体前列腺素 E 合酶 1（mPGES-1）的诱导。
J Biol Chem. 2018 Apr 6;293(14):5295-5306. doi: 10.1074/jbc.RA118.001593. Epub 2018 Feb 13.
7
Inhibition of human microsomal PGE2 synthase-1 reduces seizure-induced increases of P-glycoprotein expression and activity at the blood-brain barrier.抑制人微粒体 PGE2 合酶-1 可降低血脑屏障中 P-糖蛋白表达和活性在癫痫发作诱导下的增加。
FASEB J. 2019 Dec;33(12):13966-13981. doi: 10.1096/fj.201901460RR. Epub 2019 Oct 22.
8
Microsomal prostaglandin E synthase-1 deficiency is associated with elevated peroxisome proliferator-activated receptor gamma: regulation by prostaglandin E2 via the phosphatidylinositol 3-kinase and Akt pathway.微粒体前列腺素E合酶-1缺乏与过氧化物酶体增殖物激活受体γ升高相关：前列腺素E2通过磷脂酰肌醇3激酶和Akt途径进行调节。
J Biol Chem. 2007 Feb 23;282(8):5356-66. doi: 10.1074/jbc.M610153200. Epub 2006 Dec 22.
9
Co-localization of microsomal prostaglandin E synthase-1 with cyclooxygenase-1 in layer II of murine placental syncytiotrophoblasts.微粒体前列腺素E合酶-1与环氧化酶-1在小鼠胎盘合体滋养层细胞II层中的共定位。
Placenta. 2017 May;53:76-82. doi: 10.1016/j.placenta.2017.04.002. Epub 2017 Apr 6.
10
Inhibition of microsomal prostaglandin E-synthase-1 (mPGES-1) selectively suppresses PGE in an in vitro equine inflammation model.在体外马炎症模型中，微粒体前列腺素E合酶-1（mPGES-1）的抑制作用可选择性抑制前列腺素E（PGE）。
Vet Immunol Immunopathol. 2017 Oct;192:33-40. doi: 10.1016/j.vetimm.2017.09.008. Epub 2017 Oct 3.
引用本文的文献
1
Prostaglandins in the Inflamed Central Nervous System: Potential Therapeutic Targets.炎症性中枢神经系统中的前列腺素：潜在的治疗靶点。
Curr Drug Targets. 2024;25(13):885-908. doi: 10.2174/0113894501323980240815113851.
本文引用的文献
1
Enhanced mPGES-1 Contributes to PD-Related Peritoneal Fibrosis via Activation of the NLRP3 Inflammasome.增强的mPGES-1通过激活NLRP3炎性小体促进与腹膜透析相关的腹膜纤维化。
Front Med (Lausanne). 2021 May 18;8:675363. doi: 10.3389/fmed.2021.675363. eCollection 2021.
2
Engineering 'Enzymelink' for screening lead compounds to inhibit mPGES-1 while maintaining prostacyclin synthase activity.工程化“酶连接”筛选抑制 mPGES-1 而同时保持前列环素合酶活性的先导化合物。
Future Med Chem. 2021 Jul;13(13):1091-1103. doi: 10.4155/fmc-2021-0056. Epub 2021 Jun 3.
3
Inhibition of mPGES-1 attenuates efficient resolution of acute inflammation by enhancing CX3CL1 expression.抑制 mPGES-1 通过增强 CX3CL1 的表达来减轻急性炎症的有效消退。
Cell Death Dis. 2021 Feb 2;12(2):135. doi: 10.1038/s41419-021-03423-2.
4
Targeting microsomal prostaglandin E synthase 1 to develop drugs treating the inflammatory diseases.靶向微粒体前列腺素E合酶1以开发治疗炎症性疾病的药物。
Am J Transl Res. 2021 Jan 15;13(1):391-419. eCollection 2021.
5
Discovery and Development of a Novel mPGES-1/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases.新型mPGES-1/5-LOX双重抑制剂LFA-9用于预防和治疗慢性炎症性疾病的发现与开发
J Inflamm Res. 2020 Dec 31;13:1261-1278. doi: 10.2147/JIR.S286110. eCollection 2020.
6
DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1.DREAM 联合靶向 mPGES-1 的新型抗炎药物的鉴定策略
Sci Rep. 2020 Jun 23;10(1):10187. doi: 10.1038/s41598-020-67283-0.
7
NLRP3 Inflammasome and Inflammatory Diseases.NLRP3 炎性小体与炎症性疾病
Oxid Med Cell Longev. 2020 Feb 17;2020:4063562. doi: 10.1155/2020/4063562. eCollection 2020.
8
Mechanistic definition of the cardiovascular mPGES-1/COX-2/ADMA axis.心血管 mPGES-1/COX-2/ADMA 轴的机制定义。
Cardiovasc Res. 2020 Oct 1;116(12):1972-1980. doi: 10.1093/cvr/cvz290.
9
Biological characterization of new inhibitors of microsomal PGE synthase-1 in preclinical models of inflammation and vascular tone.在炎症和血管张力的临床前模型中对微粒体 PGE 合酶-1 的新型抑制剂的生物学特性进行研究。
Br J Pharmacol. 2019 Dec;176(24):4625-4638. doi: 10.1111/bph.14827. Epub 2019 Dec 28.
10
Myeloid Cell mPges-1 Deletion Attenuates Mortality Without Affecting Remodeling After Acute Myocardial Infarction in Mice.髓系细胞 mPges-1 缺失可减轻急性心肌梗死后小鼠的死亡率，而不影响重构。
J Pharmacol Exp Ther. 2019 Jul;370(1):18-24. doi: 10.1124/jpet.118.256057. Epub 2019 Apr 16.
Zotero 插件